Search
Analyzing Nanobiotix's P1 Head & Neck data for the radioenhancer NBTXR3 from #ASTRO2023
- blonca9
- Oct 10, 2023
- 1 min read
Updated: Oct 19, 2023
CEO Laurent Levy walks us through the data and makes his argument that patients' overall survival seen on NBTXR3 was greater than what would be expected from historical controls.